SQZ Biotech, a novel cell therapy company with Big Pharma backing, is no more. However, the company's science, and its founding CEO, will continue on under new auspices.
Life Science Leader Magazine
by
1w ago
Where Are They Now? Ono Pharmaceuticals ..read more
Visit website
OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in NSCLC, an area of acute unmet need.
Life Science Leader Magazine
by
2w ago
..read more
Visit website
In a few short years, Novo Nordisk has gone from belt-tightening to parachute pants, and is now replaying a GLP-1 competition with Eli Lilly that kicked off with Victoza and Trulicity ten years ago.
Life Science Leader Magazine
by
2M ago
..read more
Visit website
Antiva Biosciences is exploring a local and global opportunity with a topically administered HPV treatment.
Life Science Leader Magazine
by
2M ago
..read more
Visit website
Ono Pharmaceuticals continues its quest to become a global biopharmaceutical company, after discovering and helping to launch one of the most successful cancer drugs, Opdivo, in the last decade.
Life Science Leader Magazine
by
3M ago
Where Are They Now? Karuna Therapeutics ..read more
Visit website
Founded in late 2019, KeifeRx is repurposing oncology drugs for neurodegenerative disorders.
Life Science Leader Magazine
by
3M ago
..read more
Visit website
A novel small molecule developer aims to shake up the solid tumor treatment landscape.
Life Science Leader Magazine
by
3M ago
..read more
Visit website
A New Year’s Resolution Suggestion For The FDA
Life Science Leader Magazine
by
3M ago
Many pharma/biotech companies have continuing compliance problems when getting inspected by our friends at the FDA. In this article, this industry observer with almost 50 years of experience shares some New Year's resolution wishes for the FDA, and, by extension, industry members can consider the list as the foundation for sustainable quality in your operations ..read more
Visit website
Ensuring Diversity And Accessibility In Neurological Research
Life Science Leader Magazine
by
3M ago
The landscape of neurological and rare disorders is as diverse as the human population it affects. Yet, clinical trials for these conditions have not always mirrored this diversity ..read more
Visit website
Pharma’s Customer Engagement Evolution: Is Your Data Governance Keeping Pace?
Life Science Leader Magazine
by
4M ago
New tools and processes for data collection and analyses -- supported by executive leadership -- are key to engaging customers for the successful promotion of new medicines ..read more
Visit website

Follow Life Science Leader Magazine on FeedSpot

Continue with Google
Continue with Apple
OR